Protein kinase A-induced phosphorylation of the p65 subunit of nuclear factor-κB promotes Schwann cell differentiation into a myelinating phenotype

Journal of Neuroscience

Volumn 28, Issue 14, 2008, Pages 3738-3746

  Yoon, Choya ^a   Korade, Zeljka ^a,b   Carter, Bruce D ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cAMP; Glia; Myelin; Nuclear factor B; Oct 6; Schwann

Indexed keywords

ALPHA TUBULIN; BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; MYELIN; OCTAMER TRANSCRIPTION FACTOR 6; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; CYCLIC AMP; ENZYME INHIBITOR; SERINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MOUSE; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE FIBER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SCHWANN CELL; SCIATIC NERVE; SENSORY NERVE CELL; TRANSCRIPTION INITIATION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; MUTATION; MYELIN SHEATH; NERVE CELL; NEWBORN; PHOSPHORYLATION; PHYSIOLOGY; SPINAL GANGLION; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME INHIBITORS; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; MICE; MICE, TRANSGENIC; MUTATION; MYELIN SHEATH; NEURONS; PHOSPHORYLATION; RATS; SCHWANN CELLS; SCIATIC NERVE; SERINE; TRANSCRIPTION FACTOR RELA;

EID: 43649103959     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4439-07.2008     Document Type: Article

References (44)

1. Bermingham Jr JR, Scherer SS, O'Connell S, Arroyo E, Kalla KA, Powell FL, Rosenfeld MG (1996) Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev 10:1751-1762.
2. Blackwell TS, Yull FE, Chen CL, Venkatakrishnan A, Blackwell TR, Hicks DJ, Lancaster LH, Christman JW, Kerr LD (2000) Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am J Respir Crit Care Med 162:1095-1101.
3. Campbell KJ, Perkins ND (2004a) Post-translational modification of RelA(p65) NF-kappaB. Biochem Soc Trans 32:1087-1089.
4. Campbell KJ, Perkins ND (2004b) Reprogramming RelA. Cell Cycle 3:869-872.
5. Chen CL, Yull FE, Kerr LD (1999) Differential serine phosphorylation regulates IkappaB-alpha inactivation. Biochem Biophys Res Commun 257:798-806.
6. Courtois G, Gilmore TD (2006) Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene 25:6831-6843.
7. De Bosscher K, Vanden Berghe W, Haegeman G (2006) Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene 25:6868-6886.
8. Einheber S, Milner TA, Giancotti F, Salzer JL (1993) Axonal regulation of Schwann cell integrin expression suggests a role for alpha 6 beta 4 in myelination. J Cell Biol 123:1223-1236.
9. Gentry JJ, Casaccia-Bonnefil P, Carter BD (2000) Nerve growth factor activation of nuclear factor kappaB through its p75 receptor is an anti-apoptotic signal in RN22 schwannoma cells. J Biol Chem 275:7558-7565.
10. Ghazvini M, Mandemakers W, Jaegle M, Piirsoo M, Driegen S, Koutsourakis M, Smit X, Grosveld F, Meijer D (2002) A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration. EMBO J 21:4612-4620.
11. Hoffmann A, Natoli G, Ghosh G (2006) Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25:6706-6716.
12. Howe DG, McCarthy KD (2000) Retroviral inhibition of cAMP-dependent protein kinase inhibits myelination but not Schwann cell mitosis stimulated by interaction with neurons. J Neurosci 20:3513-3521.
13. Huber LJ, Chao MV (1995) A potential interaction of p75 and trkA NGF receptors revealed by affinity crosslinking and immunoprecipitation. J Neurosci Res 40:557-563.
14. Iacovelli J, Lopera J, Bott M, Baldwin E, Khaled A, Uddin N, Fernandez-Valle C (2007) Serum and forskolin cooperate to promote G1 progression in Schwann cells by differentially r regulating cyclin D1, cyclin E1, and p27(Kip) expression. Glia 55:1638-1647.
15. Jaegle M, Mandemakers W, Broos L, Zwart R, Karis A, Visser P, Grosveld F, Meijer D (1996) The POU factor Oct-6 and Schwann cell differentiation. Science 273:507-510.
16. Jessen KR, Morgan L, Brammer M, Mirsky R (1985) Galactocerebroside is expressed by non- myelin-forming Schwann cells in situ. J Cell Biol 101:1135-1143.
17. Kim HA, DeClue JE, Ratner N (1997) cAMP-dependent protein kinase A is required for Schwann cell growth: interactions between the cAMP and neuregulin/tyrosine kinase pathways. J Neurosci Res 49:236-247.
18. Kurrasch DM, Huang J, Wilkie TM, Repa JJ (2004) Quantitative real-time polymerase chain reaction measurement of regulators of G-protein signaling mRNA levels in mouse tissues. Methods Enzymol 389:3-15.
19. Leimeroth R, Lobsiger C, Lussi A, Taylor V, Suter U, Sommer L (2002) Membrane-bound neuregulin1 type III actively promotes Schwann cell differentiation of multipotent Progenitor cells. Dev Biol 246:245-258.
20. Lemke G, Chao M (1988) Axons regulate Schwann cell expression of the major myelin and NGF receptor genes. Development 102:499-504.
21. Lemke GE, Brockes JP (1984) Identification and purification of glial growth factor. J Neurosci 4:75-83.
22. Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA (2004) Axonal neuregulin-1 regulates myelin sheath thickness. Science 304:700-703.
23. Mirsky R, Dubois C, Morgan L, Jessen KR (1990) 04 and A007-sulfatide antibodies bind to embryonic Schwann cells prior to the appearance of galactocerebroside; regulation of the antigen by axon-Schwann cell signals and cyclic AMP. Development 109:105-116.
24. Monje PV, Bartlett Bunge M, Wood PM (2006) Cyclic AMP synergistically enhances neuregulin-dependent ERK and Akt activation and cell cycle progression in Schwann cells. Glia 53:649-659.
25. Monuki ES, Weinmaster G, Kuhn R, Lemke G (1989) SCIP: a glial POU domain gene regulated by cyclic AMP. Neuron 3:783-793.
26. Morgan L, Jessen KR, Mirsky R (1991) The effects of cAMP on differentiation of cultured Schwann cells: progression from an early phenotype (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition. J Cell Biol 112:457-467.
27. Nickols JC, Valentine W, Kanwal S, Carter BD (2003) Activation of the transcription factor NF- kappaB in Schwann cells is required for peripheral myelin formation. Nat Neurosci 6:161-167.
28. Perkins ND, Gilmore TD (2006) Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ 13:759-772.
29. Raff MC, Hornby-Smith A, Brockes JP (1978a) Cyclic AMP as a mitogenic signal for cultured rat Schwann cells. Nature 273:672-673.
30. Raff MC, Abney E, Brockes JP, Hornby-Smith A (1978b) Schwann cell growth factors. Cell 15:813-822.
31. Rahmatullah M, Schroering A, Rothblum K, Stahl RC, Urban B, Carey DJ (1998) Synergistic regulation of Schwann cell proliferation by heregulin and forskolin. Mol Cell Biol 18:6245-6252.
32. Ratner N, Glaser L, Bunge RP (1984) PC12 cells as a source of neurite-derived cell surface mitogen, which stimulates Schwann cell division. J Cell Biol 98:1150-1155.
33. Shuman S, Hardy M, Sobue G, Pleasure D (1988) A cyclic AMP analogue induces synthesis of a myelin-specific glycoprotein by cultured Schwann cells. J Neurochem 50:190-194.
34. Sobue G, Pleasure D (1984) Schwann cell galactocerebroside induced by derivatives of adenosine 3′,5′-monophosphate. Science 224:72-74.
35. Sobue G, Shuman S, Pleasure D (1986) Schwann cell responses to cyclic AMP: proliferation, change in shape, and appearance of surface galactocerebroside. Brain Res 362:23-32.
36. Stewart HJ, Eccleston PA, Jessen KR, Mirsky R (1991) Interaction between cAMP elevation, identified growth factors, and serum components in regulating Schwann cell growth. J Neurosci Res 30:346-352.
37. Sun Z, Andersson R (2002) NF-kappaB activation and inhibition: a review. Shock 18:99-106.
38. Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, Einheber S, Xu X, Esper RM, Loeb JA, Shrager P, Chao MV, Falls DL, Role L, Salzer JL (2005) Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47:681-694.
39. Van Waes C (2007) Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin Cancer Res 13:1076-1082.
40. Webster HD (1971) The geometry of peripheral myelin sheaths during their formation and growth in rat sciatic nerves. J Cell Biol 48:348-367.
41. Yamada H, Komiyama A, Suzuki K (1995) Schwann cell responses to forskolin and cyclic AMP analogues: comparative study of mouse and rat Schwann cells. Brain Res 681:97-104.
42. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S (1997) The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89:413-424.
43. Zhong H, Voll RE, Ghosh S (1998) Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1:661-671.
44. Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G (1996) The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci 8:129-145.